Product Protocols: TSC22D4 antibody tested with Human Hepg2 Cells (ARP30107_T100)

Aviva Systems Biology is the original manufacturer of this TSC22D4 antibody (ARP30107_T100)

Click here to view the TSC22D4 antibody Western Blot Protocol

Product Datasheet Link: TSC22D4 antibody (ARP30107_T100)

WB Suggested Anti-TSC22D4 Antibody Titration: 0.5ug/ml
ELISA Titer: 1:62500
Positive Control: HepG2

Western Blot image:


Description of Target: TSC22D4 is a leucine zipper-containing protein that is highly conserved during evolution. It is transcriptionally up-regulated by many different stimuli, including anti-cancer drugs and growth inhibitors. TSC22D4 may play a suppressive role in tumorigenesis.

Questions pertaining to this data can be directed to techsupport@avivasysbio.com

Aviva Systems Biology’s TSC22D4 antibody (ARP30107_T100) has been tested using other cell lysates and tissues. To obtain more data about this antibody please email us at info@avivasysbio.com.

To order by phone call us at (888) 880-0001, fax us at (858) 552-6975 or send an email to info@avivasysbio.com. Aviva manufactures this antibody so we can offer the best price. Please contact us to request pricing information.

All of Aviva’s products are guaranteed for the applications and experimental sample types mentioned in the datasheet below. Are you curious if this product will work for you? Please contact us at techsupport@avivasysbio.com

This entry was posted in Western Blot Protocols and tagged , , , , , , . Bookmark the permalink.

Leave a Reply